
zzso is an zzso that began clinical trials during the 1960s based on its level of zzso activity in zzso tumor zzso Phase I studies were performed using an oral zzso given in divided doses for varying numbers of zzso The most frequently reported zzso included zzso zzso abdominal zzso zzso weight loss and zzso Less frequently reported zzso were zzso zzso zzso and peripheral zzso Clinical zzso activity was noted in the phase I studies in a variety of tumor zzso Since then a large number of studies have been performed using zzso as a single agent and in a variety of zzso Unfortunately, almost none of these studies sought to define the utility of this drug relative to other treatments for the diseases in which it showed activity, or to define the contribution of this drug to the activity of any given zzso Thus its role in the treatment of patients with zzso remains zzso 

